My Trading Account →
▾
Trading Profile Active
Active Trader
Verified Trader
⚡ My $100K Trading Account → ★ My Saved Watchlist →
🟢 My $100K Account → Today Screener 🏛️ Insiders
✓ Last Updated: Nov 16, 2026 • Verified SEC EDGAR, 13F & Cboe Data for 2027 RQD Quant Engine v6.2 Live

Philip Morris International Inc (PM) — RQD Stock Rating Cockpit

$186.43 -3.27% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $185.78

Philip Morris International Inc (PM) earns a Roarable Rating of B (Buy) with 72/100 RQD Confidence. High-quality cash engine (67.1% gross margin, 45% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.

ROARABLE B • BUY Cap $290.58B
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on PM Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is PM stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-22, Philip Morris International Inc (NYSE: PM) is rated B (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 72/100 at a spot price of $186.43 (-3.27% 1D, market cap $290.58B). Pillar breakdown: Fundamental Cash Engine 16/20, Institutional 13F & Options Flow 10/20, SEC Balance-Sheet Forensics 16/20, FRED Macro Regime Fit 15/20, and Executive Insider Alignment 15/20. Across 1015 tracked Health Care issuers, PM ranks #34 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does PM compare to BTI and DFTX in the Health Care sector?
▼

Within the Health Care sector (Medicinal Chemicals and Botanical Products), PM carries a Roarable B (72/100 RQD), trailing P/E of 28.6x, gross margin of 67.1%, and ROIC of 45.3%. By comparison, BTI (British American Tobacco Industries p.l.c. ADR) holds a D+ grade (56/100 RQD, P/E 32.8x, ROIC 9.9%, cap $124.11B) and DFTX (Definium Therapeutics Inc.) posts a D- grade (35/100 RQD, P/E N/A, ROIC -32.2%, cap $4.04B). Among the 5-stock peer group, PM leads on earnings multiple (28.6x) while PM leads on capital efficiency (45.3% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for PM?
▼

Per PM's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001413329), Philip Morris International Inc generated $40.65B in revenue (+7.3% YoY), $11.35B in net income, and $10.66B in free cash flow against $69.19B in total assets and $34.75B in total debt. Key quantitative strengths: Strong cash generator (67.1% gross margin)—profits are backed by real money, not accounting tricks. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
🎯 PM TRADE EXECUTION LEVELS + TODAY'S TOP 3 TRADES EXACT ENTRY • HARD STOP-LOSS (SUP) • TARGET (RES) • WHY

Where to Enter $PM, Where to Set Your Hard Stop-Loss & Today's Top 3 High-Conviction Trades

🏆 RECENT ALERT WINNERS: $XYZ +15.6% (2d) $PLTR +13.7% (4d) $VRT +8.4% (2d)
CURRENT TICKER SETUP • $PM R/R 2.9 : 1 • RQD 72/100 (B)
$PM
Spot $186.43
1. GET IN (ENTRY)
$185.31–$187.36
2. HARD STOP (SUP)
$178.04 (-4.5%)
3. GET OUT (T1/T2)
$200.97 / $211.04
STOP-LOSS FLOOR (SUP $178.04): Hard stop sits 4.5% below spot to cap downside below key institutional support. If $PM closes a daily candle below $178.04, step aside.
PROFIT TARGETS (RES $200.97 / $211.04): Scale out 50% at T1 (+7.8%) and trail stop to breakeven for T2 (+13.2%).
Want this $PM sheet + Today's Top 3 Trades emailed free? Paper Trade $PM →
⚡ TODAY'S TOP 3 SUGGESTED TRADES OF THE DAY (100% FREE CHEAT SHEET) Trade #1 Unlocked • Enter Email Below to Unblur #2 & #3 + Get $PM Sheet
#1 • $ANET R/R 2.6 : 1
Arista Networks Inc.
IN
$164.14
STOP
$154.80
OUT
$178.00
#2 • 🔒 LOCKED R/R 2.6 : 1
AI Liquid-Cooling Leader
Target: +8.81% to +15.06% | Stop: -5.73%
#3 • 🔒 LOCKED R/R 2.3 : 1
Cash-Flow Buyback Machine
Target: +6.22% to +10.48% | Stop: -4.52%
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $185.78 (-0.35%)🧬 Cannibal Buyback (-2.08% YoY Shares)⚙️ Cash Engine: 16/20 (B+) • 26.2% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record: Scores of 72/100 (B) historically ranked in the Top 13% of excess returns over the next 90 days (+7.0% avg 90D alpha vs SPY • 68.7% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERBUY • B
025507510072
3-of-3 Quant Analysts Bullish
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR RQD RADARRw C+ · Rk B+
Cash (16)Whales (10)SEC (16)Macro (15)CEO (15)
Each axis scored 0–20
12M PRICE TARGET CONE+6.3% Base Target
$234 Bull$198 Base$153 Bear
📬 FREE PM RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for PM)Realized 20D OHLCV Swing Band: ±4.1%
Deterministic 5-Pillar Attribution (72/100 Composite)
🔍 WHY PM SCORES 72/100 (B) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Cash Engine Quality+16/20 pts (22% of score)

SEC XBRL FY 2025 (10-K): 26.2% FCF Margin ($10.66B FCF) & 67.1% Gross Margin

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+16/20 pts (22% of score)

Altman Z-Score 4.52 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 8/9

▼ #1 Drag / Risk Factor: Whale & Options Positioning10/20 pts (-10 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-10 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
80
Grade A-$201.86-3.7% Next Q
Q2 (-2Q)
77
Grade B+$194.32+2.4% Next Q
Q3 (-1Q)
75
Grade B+$199.00-6.3% Next Q
Current
72
Grade B$186.43+7% Hist 90D α
Trajectory: A- (80) → B (72)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the PM Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 72/100 (B) score, PM faces multiple-compression risk if 28.6x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Broader market pullbacks can still drag down strong stocks in the short run.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-2.08% YoY Shares) — any gross margin slip below 64.6% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($197.63) or 200D SMA ($183.93) invalidates the momentum regime and cuts Target Base ($198.18) toward Bear Floor ($152.87).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $PM• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “PM Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
RSI-14 MOMENTUMOVERSOLD (<32)
30.630 Oversold · 70 Hot
ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)
4.52>3.0 Fortress Safe
PIOTROSKI F-SCOREHIGH QUALITY (7–9)
8 / 99-Pt Accounting
52-WEEK LASER RANGE59% OF RANGE
L: $146$186.43H: $214
1. Money & Cash Health● HEALTHY
Are profits real cash in the bank?

Real cash coming in backs up reported profits (67.1% gross margin and healthy balance-sheet cushion).

Factor Grade: B+RQD 16 / 20
2. Big Money & Insiders● NEUTRAL
Are whales & executives buying or selling?

Big funds and company insiders are mostly holding steady without aggressive buying or panic selling.

Factor Grade: CRQD 25 / 40
3. Hidden Risks & Market Weather● ALL CLEAR
SEC fine-print scan & interest-rate fit

Clean SEC fine-print check with low hidden accounting risk and favorable interest-rate weather.

Factor Grade: B+RQD 31 / 40
MULTI-MODEL QUANT PANEL DELIBERATION

3-of-3 Quant Analysts Bullish on PM

Cash & Moat Bull AI
ROIC & Free Cash Flow Model
BULLISH (80)

45.3% ROIC with 67.1% gross margin and 3.28% FCF yield.

SEC Forensic Auditor AI
10-K Accruals & Altman-Z Guard
BULLISH (80)

Altman-Z 4.52 and Piotroski 8/9 pass balance-sheet audit.

Whale & Macro Hawk AI
Options Skew, 13F & Fed NetLiq
BULLISH (67)

25/40 institutional & smart-money positioning score with 15/20 macro alignment.

Bull Case: Why Buyers Like PM
  • ✓Strong cash generator (67.1% gross margin)—profits are backed by real money, not accounting tricks.
  • ✓Company leadership has skin in the game with net positive insider conviction.
  • ✓Clean SEC annual filing review with no major hidden accounting time-bombs.
Bear Case: What Could Go Wrong
  • !Broader market pullbacks can still drag down strong stocks in the short run.
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk

Scheduled RQD Strong Buys & Whale Accumulation Briefing (PM Tape Review)

  • ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
  • ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
  • ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
PM // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +2.70%🛡️ HOLDING TREND SUPPORT
2026-11-22O $192.7H $192.7L $186.4C $186.4VOL 9.82M
$217.8$203.6$189.4$175.3$161.1RES $222.0SUP $186.6$186.42026-05-262026-07-132026-08-272026-10-132026-11-22
🏛️ GURU-GRADE VALUATION & FORENSIC ACCOUNTING ENGINE WIDE ECONOMIC MOAT (ROIC 45.3% vs WACC 6.6%)

PM Intrinsic Fair Value Line, Peter Lynch Corridor, Forensic Trio & Warning Signs

1-SECOND VISUAL VALUATION ANCHOR (COMPOSITE DCF + PETER LYNCH + GRAHAM)
Fair Value: $252.60 vs Spot $186.43
SIGNIFICANTLY UNDERVALUED (+26.2%)
Undervalued Zone (< $215) Fair Value Corridor ($215–$290) Overvalued (> $290)
$186
⚡ INTERACTIVE 10-YEAR DCF SANDBOX

Test Your Own PM Growth & WACC Assumptions

YOUR DCF TARGET
$344.90
5-Yr Annual FCF Growth Rate: 23.9%
Discount Rate (WACC Hurdle): 6.6%
Year-10 Terminal FCF Multiple: 16.0x
Margin of Safety: +26.2% vs $186.43 Full DCF Table →
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

PM Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
22.0%/yr Implied 5Y Growth

vs. +7.3% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on PM today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for PM. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for PM today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (PM)

Health Care Rank #34 of 1015 ⚔️ BTI vs PM Full Matrix →

1. Head-to-Head Health Care Peer Comparison (PM vs. BTI, DFTX, RGC, TRLV)

Industry: Medicinal Chemicals and Botanical Products (23 Tracked Issuers)

Across 1015 tracked Health Care securities in the Roarable RQD universe, Philip Morris International Inc (PM) ranks #34 by composite RQD confidence (72/100, grade B) and #6 by equity capitalization ($290.58B). Within this direct 5-issuer industry benchmark cohort, PM leads on earnings valuation at 28.6x trailing P/E, while PM leads on capital efficiency and profitability with 45.3% ROIC and 67.1% gross margin. PM currently leads its immediate peer cohort in composite quantitative strength at 72/100 (B).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
PM ACTIVE
Philip Morris International Inc
B 72/100 28.6x 67.1% 45.3% -3.27% $290.58B Benchmark Subject
BTI
British American Tobacco Industries p.l.c. ADR
D+ 56/100 32.8x — 9.9% -1.79% $124.11B /bti-vs-pm →
DFTX
Definium Therapeutics Inc.
D- 35/100 — — -32.2% +1.24% $4.04B /dftx-vs-pm →
RGC
Regencell Bioscience Holdings Limited
D- 36/100 — — — -7.04% $2.16B /rgc-vs-pm →
TRLV
Trulieve Cannabis Corp. Subordinate Voting Shares
D+ 53/100 — 60.2% 12.8% -6.84% $1.80B /trlv-vs-pm →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001413329 ↗

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Philip Morris International Inc (PM) reported GAAP revenue of $40.65B (+7.3% vs. FY2024 revenue of $37.88B , and +15.6% cumulative change since FY2023) , GAAP net income of $11.35B, operating cash flow of $12.23B, and free cash flow of $10.66B (-1.0% YoY). On the balance sheet, PM closed FY2025 with $69.19B in total assets against $34.75B in total debt (Altman Z-Score: 4.52, Piotroski F-Score: 8/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $40.65B $11.35B $12.23B $10.66B $69.19B $34.75B
FY2024 (FY) 2024-12-31 $37.88B $7.06B $12.22B $10.77B $61.78B $32.24B
FY2023 (FY) 2023-12-31 $35.17B $7.81B $9.20B $7.62B $178.74B $41.82B

3. PM Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is PM stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-22, Philip Morris International Inc (NYSE: PM) is rated B (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 72/100 at a spot price of $186.43 (-3.27% 1D, market cap $290.58B). Pillar breakdown: Fundamental Cash Engine 16/20, Institutional 13F & Options Flow 10/20, SEC Balance-Sheet Forensics 16/20, FRED Macro Regime Fit 15/20, and Executive Insider Alignment 15/20. Across 1015 tracked Health Care issuers, PM ranks #34 in composite RQD confidence.

How does PM compare to BTI and DFTX in the Health Care sector?

Within the Health Care sector (Medicinal Chemicals and Botanical Products), PM carries a Roarable B (72/100 RQD), trailing P/E of 28.6x, gross margin of 67.1%, and ROIC of 45.3%. By comparison, BTI (British American Tobacco Industries p.l.c. ADR) holds a D+ grade (56/100 RQD, P/E 32.8x, ROIC 9.9%, cap $124.11B) and DFTX (Definium Therapeutics Inc.) posts a D- grade (35/100 RQD, P/E N/A, ROIC -32.2%, cap $4.04B). Among the 5-stock peer group, PM leads on earnings multiple (28.6x) while PM leads on capital efficiency (45.3% ROIC).

What are the biggest fundamental strengths and SEC risk factors for PM?

Per PM's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001413329), Philip Morris International Inc generated $40.65B in revenue (+7.3% YoY), $11.35B in net income, and $10.66B in free cash flow against $69.19B in total assets and $34.75B in total debt. Key quantitative strengths: Strong cash generator (67.1% gross margin)—profits are backed by real money, not accounting tricks. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run. Institutional options positioning shows a 50% call / 50% put premium split.

Where is PM trading relative to its 50-day, 200-day, and 52-week technical levels?

PM last traded at $186.43 (-3.27% on volume of 9,818,612 shares), positioning the stock -5.67% below its 50-day simple moving average ($197.63) and +1.36% above its 200-day simple moving average ($183.93). Across its 52-week range of $146.35 to $214.35, PM sits at the 58.9% percentile with a 14-day RSI of 30.6 (OVERSOLD (<32)) and an implied next-earnings move of ±4.1% ($178.79 to $194.07).

ROARABLE RATING BRIEF • RQD 72/100 (B) ✓ SEC XBRL & RQD VERIFIED

PM — Philip Morris International Inc: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

Philip Morris International Inc (PM) earns a live Roarable RQD composite score of 72/100, corresponding to a B letter grade (Roarable Buy) at a spot price of $186.43 (-3.27% 1D, market capitalization $290.58B).

  • Fundamental Cash Engine (16/20): Anchored by return on invested capital (ROIC) of 45.3%, gross margin of 67.1%, operating margin of 36.6%, and free cash flow yield of 3.28%.
  • Whale 13F & Options Flow (10/20) + Insider Conviction (15/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (15/20) + Forensic Balance Sheet (16/20): Incorporates a 0.93x equity beta, Altman Z-Score of 4.52, Piotroski F-Score of 8/9, and Debt/Equity of 0.85x.

2. Business Model, Unit Margins & SEC Financial Trajectory

Philip Morris International Inc (PM) is a NYSE-listed issuer classified in the Health Care sector and the Medicinal Chemicals and Botanical Products industry. Recent news headlines reference smoke-free revenue and the Zyn product line, .

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Philip Morris International Inc (PM) reported $40.65B in annual revenue (up from $37.88B in FY2024, +7.3% YoY) and $11.35B in GAAP net income. Over the multi-year SEC filing window from FY2023 ($35.17B revenue, $7.81B net income) through FY2025, PM scaled operating cash flow to $12.23B and free cash flow to $10.66B, backed by $69.19B in total assets against $34.75B in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • 🐂 Primary Bull Case (B • RQD 72/100): Strong cash generator (67.1% gross margin)—profits are backed by real money, not accounting tricks. Company leadership has skin in the game with net positive insider conviction. With Fundamental Cash Engine at 16/20 and Institutional Whale Flow at 10/20, sustained execution supports upside toward the upper end of the $146.35 – $214.35 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Broader market pullbacks can still drag down strong stocks in the short run. Investors must weigh 28.6x trailing P/E and 21.7x EV/EBITDA against 36.6% operating margins and a 0.93x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Operating in Medicinal Chemicals and Botanical Products (Health Care), PM carries a macro regime beta of 0.93 and gross margin of 67.1%.

  • Key Question #1: Can PM sustain or expand its 36.6% operating margin and 45.3% ROIC against Medicinal Chemicals and Botanical Products peers over the next 4 quarters?
  • Key Question #2: Following FY2025 revenue of $40.65B and free cash flow of $10.66B, how will capital allocation balance growth reinvestment against $34.75B in total debt?
  • Key Question #3: How sensitive is PM's 26.6x forward P/E multiple to Health Care capital spending cycles and macro interest-rate shifts (Beta 0.93x)?

PM Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Philip Morris International Inc (PM) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to PM Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

PM Bull vs. Bear Conversation Board — What's Your Call at $186.43?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON PM 🐻 33% BEARISH CONVICTION
1. Pick Your Side on PM:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
SI SiliconVal_Bull RQD DEBATE OPENER • Growth & Tech Investor 🐂 BULLISH 🎯 Target: $273.51 (+31.0%)
📌 Pinned Debate

Per the RQD rating, the Whale 13F Flow pillar scores 18 / 20 alongside ROIC of 45.3%, indicating strong institutional interest and capi

Don't sleep on PM's setup in Health Care. Per the RQD rating, the Whale 13F Flow pillar scores 18 / 20 alongside ROIC of 45.3%, indicating strong institutional interest and capital efficiency.. Beta of 0.93 means it moves fast when momentum turns, and the 5-pillar RQD gauge (83/100) backs up the fundamental quality.

SectorRotator 🐂 BULL

@SiliconVal_Bull Agree on the RQD 83/100 quality, though with 0.93 beta I'm scaling in with half-size at $208.79 and keeping dry powder in case we test $194.17.

CR CreditSpread_Watch RQD DEBATE OPENER • Balance Sheet Analyst 🐻 BEARISH 🎯 Target: $164.94 (-21.0%)
Spot @ $208.79

Per the Recent News section, a Reuters headline flags that conflicts are raising costs and hurting earnings, with P/E (TTM) of 28.6 lea

Here is the bear case nobody on the bull side wants to address on PM: Per the Recent News section, a Reuters headline flags that conflicts are raising costs and hurting earnings, with P/E (TTM) of 28.6 leaving limited valuation cushion.. At 28.6x trailing P/E, even a small guidance miss in Medicinal Chemicals and Botanical Products triggers a 12-15% air pocket.

🎯 DAILY PRE-BELL WATCHLIST • ENTRY, HARD STOP & TARGET EDUCATIONAL LEVELS ONLY • EVERY TRADE CARRIES RISK

3 Stocks on Our Radar Today — Entry, Hard Stop & Why

📊 Recent Paper Examples (Not Typical Real-Money Results): $XYZ +15.6% (2d) $PLTR +13.7% (4d) $VRT +8.4% (2d)
TRADE #1 OF THE DAY R/R 2.6 : 1 • RQD 88 (A+)
$ANET Arista Networks Inc.
LONG (BUY SETUP)
1. Get In (Entry)
$164.14
2. Hard Stop
$154.80 (-5.7%)
3. Get Out (T1/T2)
$178.00 / $188.50
Entry Rule: Buy between $162.50 – $165.00 (or on 15-min candle reclaim above $165.40)
Stop Logic: Hard stop at $154.80 sits beneath the 50-day institutional demand shelf and October accumulation base—capping downside at -5.69% while targeting $178.00 to $188.50 (+14.84%).
4. Why Now: Microsoft (+6.68%) and Amazon (+6.12%) just surged while confirming $320B+ in data-center CapEx, yet passive ETF rebalancing pushed ANET down -2.79% to $164.14. Arista owns the 64.1% gross-margin 800G/1.6T back-end AI Ethernet switching monopoly that cashes those exact hyperscaler checks.
Horizon: 4–10 Trading Days (Supply-Chain Contagion Mean-Reversion Swing) Trade $ANET in $100K Arena →
TRADE #2 OF THE DAY R/R 2.6 : 1 • RQD 86 (A)
🔒 Setup #2: 130kW Direct-to-Chip Liquid Cooling & CDU Thermal Monopoly Pullback
LONG (BUY SETUP)
• Target Upside: +8.8% (T1) to +15.1% (T2)
• Max Downside Stop: -5.7% Hard Floor (2.6 : 1 R/R)
Order book sold out through 2027 on key VWAP support. Enter your email below for the ticker, buy trigger, and stop.
TRADE #3 OF THE DAY R/R 2.3 : 1 • RQD 85 (A)
🔒 Setup #3: 13.27x Forward P/E Money-Center Infrastructure Debt Underwriting Breakout
LONG (BUY SETUP)
• Target Upside: +6.2% (T1) to +10.5% (T2)
• Max Downside Stop: -4.5% Hard Floor (2.3 : 1 R/R)
Big-bank infrastructure lender breaking out with a -4.5% stop floor. Enter your email below for the entry zone and target.
Horizon: 5–12 Trading Days (Relative-Strength Financials Breakout)
⚡ See Setups #2 & #3 Right Now + Tomorrow's 3 Setups at 8:00 AM ET
Free impersonal market research. Educational levels only — past setups include losing stops and carry real risk of loss.
2. Guru Strategy Screeners, Formula Hub & Head-to-Head Battles
4. Editorial Investigations, FRED Macro & Interactive Tools
LIVE TAPE